ALICIA FLOREZ: Open Payments
NPI 1053727008 · SAINT HELENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 17 payments from 11 companies in 2025. Trend: 2023 $7 · 2024 $520 · 2025 $561
Food & beverage: $461Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| Janssen Biotech, Inc. | 2 | $121 |
| Celgene Corporation | 3 | $60 |
| Daiichi Sankyo Inc. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| Lilly USA, LLC | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $24 |
| BeiGene USA, Inc. | 1 | $24 |
Products named: ENHERTU, DARZALEX, REBLOZYL, Nubeqa, VERZENIO, XPOVIO, EPKINLY, Vyloy.
Industry payments across CA — which companies pay providers there.
